Early clinical trials have shown promising results, with agents like semaglutide and exenatide demonstrating reductions in alcohol consumption and craving, as well as potential benefits for smoking cessation, such as reduced post-cessation weight gain
doi:10.1152/physrev.00034.2006 108
Options include topical or oral minoxidil, antihormonal therapies such as spironolactone (for women), or 5-alpha reductase inhibitors such as finasteride or dutasteride
This may involve modifying the dose, changing medication timing, addressing behavioral patterns, or transitioning to a different medication class
Liver Fat & Inflammation In a MASLD study, Retatrutide achieved over 80% liver-fat reduction and normalised liver enzymes in most participants
El-Ouaghlidi, A